PharmaCyte Biotech (PMCB) went public on September 17, 2010, when it opened at a split-adjusted price of $10.23.
| DATE | OPEN | HIGH | LOW | CLOSE | VOLUME |
|---|---|---|---|---|---|
November 2025 | $0.93 | $0.94 | $0.63 | $0.65 | 455,015 |
October 2025 | $0.95 | $1.06 | $0.92 | $0.93 | 1,281,100 |
September 2025 | $1.00 | $1.25 | $0.91 | $0.97 | 2,966,900 |
August 2025 | $1.02 | $1.13 | $0.80 | $0.94 | 2,347,400 |
July 2025 | $1.10 | $1.15 | $0.95 | $1.02 | 528,000 |
June 2025 | $1.01 | $1.14 | $1.00 | $1.09 | 202,600 |
May 2025 | $1.30 | $1.39 | $1.00 | $1.03 | 202,500 |
April 2025 | $1.22 | $1.40 | $1.03 | $1.24 | 287,000 |
March 2025 | $1.78 | $1.82 | $1.23 | $1.25 | 304,800 |
February 2025 | $1.61 | $1.90 | $1.45 | $1.76 | 576,800 |
January 2025 | $1.57 | $1.80 | $1.50 | $1.60 | 267,100 |
December 2024 | $1.71 | $1.81 | $1.53 | $1.57 | 295,200 |
November 2024 | $1.84 | $1.94 | $1.56 | $1.71 | 295,900 |
October 2024 | $1.87 | $2.42 | $1.65 | $1.81 | 1,224,600 |
September 2024 | $1.55 | $2.19 | $1.45 | $1.91 | 696,400 |
August 2024 | $1.96 | $2.00 | $1.39 | $1.53 | 315,700 |
July 2024 | $2.00 | $2.22 | $1.95 | $1.96 | 187,100 |
June 2024 | $1.98 | $2.41 | $1.88 | $1.96 | 744,000 |
May 2024 | $2.12 | $2.25 | $1.76 | $1.96 | 195,500 |
April 2024 | $2.36 | $2.55 | $2.07 | $2.12 | 359,200 |
March 2024 | $2.08 | $2.58 | $1.94 | $2.37 | 987,800 |
February 2024 | $2.17 | $2.24 | $2.00 | $2.10 | 243,000 |
January 2024 | $2.20 | $2.35 | $2.11 | $2.19 | 365,800 |
December 2023 | $2.24 | $2.39 | $2.15 | $2.16 | 360,000 |
November 2023 | $2.16 | $2.36 | $1.92 | $2.26 | 323,200 |
